Lotus Pharmaceutical Co (TPE:1795) E10: NT$8.24 (As of Dec. 2025)


TPE:1795 Lotus Pharmaceutical Co Ltd TPE:1795
76 GF Score
Price NT$183.00
GF Value NT$441.58
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Lotus Pharmaceutical Co E10?

Lotus Pharmaceutical Co TPE:1795 -3.17% 76 E10 is NT$8.24 as of Dec. 2025. GuruFocus rates TPE:1795 with a GF Score™ of 76/100 and a GF Value™ of NT$441.58 (Possible Value Trap). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Lotus Pharmaceutical Co's adjusted earnings per share data for the three months ended in Dec. 2025 was NT$4.270. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is NT$8.24 for the trailing ten years ended in Dec. 2025.

During the past 12 months, Lotus Pharmaceutical Co's average E10 Growth Rate was 30.40% per year. During the past 3 years, the average E10 Growth Rate was 54.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Lotus Pharmaceutical Co was 134.50% per year. The lowest was 54.40% per year. And the median was 94.45% per year.

As of today (2026-06-29), Lotus Pharmaceutical Co's current stock price is NT$183.00. Lotus Pharmaceutical Co's E10 for the quarter that ended in Dec. 2025 was NT$8.24. Lotus Pharmaceutical Co's Shiller PE Ratio of today is 22.21.

During the past 13 years, the highest Shiller PE Ratio of Lotus Pharmaceutical Co was 4745.00. The lowest was 22.21. And the median was 69.94.


Lotus Pharmaceutical Co  (TPE:1795) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Lotus Pharmaceutical Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=183.00/8.24
=22.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Lotus Pharmaceutical Co was 4745.00. The lowest was 22.21. And the median was 69.94.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Lotus Pharmaceutical Co E10 Related Terms


Lotus Pharmaceutical Co E10 Historical Data

* Premium members only.

The historical data trend for Lotus Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lotus Pharmaceutical Co E10 Chart

Lotus Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.49 2.24 3.95 6.32 8.24

Lotus Pharmaceutical Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.32 6.96 7.25 7.85 8.24

TPE:1795 vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Lotus Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lotus Pharmaceutical Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lotus Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Lotus Pharmaceutical Co's Shiller PE Ratio falls into.


TPE:1795
76GF Score
Lotus Pharmaceutical Co Ltd TPE:1795
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lotus Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Lotus Pharmaceutical Co's adjusted earnings per share data for the three months ended in Dec. 2025 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=4.27/324.0540*324.0540
=4.270

Current CPI (Dec. 2025) = 324.0540.

Lotus Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201603 0.270 238.132 0.367
201606 0.070 241.018 0.094
201609 -0.140 241.428 -0.188
201612 -0.766 241.432 -1.028
201703 -0.300 243.801 -0.399
201706 0.150 244.955 0.198
201709 0.200 246.819 0.263
201712 0.040 246.524 0.053
201803 0.070 249.554 0.091
201806 -0.230 251.989 -0.296
201809 0.280 252.439 0.359
201812 0.303 251.233 0.391
201903 1.160 254.202 1.479
201906 0.200 256.143 0.253
201909 0.820 256.759 1.035
201912 0.570 256.974 0.719
202003 0.540 258.115 0.678
202006 1.230 257.797 1.546
202009 1.150 260.280 1.432
202012 1.300 260.474 1.617
202103 1.840 264.877 2.251
202106 1.380 271.696 1.646
202109 1.330 274.310 1.571
202112 0.950 278.802 1.104
202203 1.710 287.504 1.927
202206 1.250 296.311 1.367
202209 7.930 296.808 8.658
202212 0.630 296.797 0.688
202303 4.550 301.836 4.885
202306 4.840 305.109 5.141
202309 4.750 307.789 5.001
202312 1.510 306.746 1.595
202403 3.940 312.332 4.088
202406 5.060 314.175 5.219
202409 5.950 315.301 6.115
202412 4.270 315.605 4.384
202503 5.440 319.799 5.512
202506 2.790 322.561 2.803
202509 5.510 324.800 5.497
202512 4.270 324.054 4.270

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of NT$8.24 mean?
Lotus Pharmaceutical Co (TPE:1795) has a E10 of NT$8.24 as of Dec. 2025. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Lotus Pharmaceutical Co and its competitors.
Is Lotus Pharmaceutical Co's E10 too high?
Lotus Pharmaceutical Co's current E10 is NT$8.24. Overall, Lotus Pharmaceutical Co has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Lotus Pharmaceutical Co's E10 compare to ZTS and UTHR?
Lotus Pharmaceutical Co's E10 of NT$8.24 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Lotus Pharmaceutical Co and its competitors. Lotus Pharmaceutical Co's current E10 is NT$8.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lotus Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Lotus Pharmaceutical Co (TPE:1795) is currently considered Possible Value Trap. The stock's GF Value™ is NT$441.58, compared to a current price of NT$183.00 — trading 58.6% below its estimated fair value. The current E10 is NT$8.24. Lotus Pharmaceutical Co's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Lotus Pharmaceutical Co (TPE:1795), the current E10 is NT$8.24 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lotus Pharmaceutical Co (TPE:1795) Overvalued in 2026?

Based on GuruFocus' analysis, Lotus Pharmaceutical Co stock appears to be undervalued. The current stock price of NT$183.00 is trading 58.6% below its estimated GF Value™ of NT$441.58. GuruFocus considers Lotus Pharmaceutical Co to be Possible Value Trap.

Key valuation signals for TPE:1795:

  • E10: NT$8.24
  • GF Value™: NT$441.58 vs. price of NT$183.00 (58.6% below fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the TPE:1795 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Lotus Pharmaceutical Co Business Description

Address Song Ren Road, No. 277, 17th Floor, Xin Yi District, Taipei, TWN, 11046
Lotus Pharmaceutical Co Ltd is engaged in the healthcare sector. Along with its subsidiaries, it is engaged in the research and development, manufacturing, and sales of generic and branded pharmaceutical products, as well as consulting services. Its product portfolio comprises biosimilars, generic medicines, branded medicines, and various therapies in its research and development pipeline. The Group offers a differentiated portfolio of pharmaceuticals spanning several therapeutic areas, including oncology and immunology, CNS, women's health, primary care and lifestyle, and nephrology, among others. Geographically, it generates maximum revenue from the United States, and the rest from Taiwan, South Korea, Singapore, and other countries.
76GF Score

Get the complete analysis for TPE:1795

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$183.00
Price
NT$441.58
GF Value